Literature DB >> 22227560

FDG PET/CT interobserver agreement in head and neck cancer: FDG and CT measurements of the primary tumor site.

Tatianie Jackson1, Margaret K Chung, Gustavo Mercier, Al Ozonoff, Rathan M Subramaniam.   

Abstract

BACKGROUND: Interobserver agreement in measuring positron emission tomography (PET)/computed tomography (CT) parameters is critical for head and neck cancer management. The purpose of this study is to assess the interobserver agreement when measuring the standardized uptake value (SUV) parameters and the diameter of primary head and neck tumors between readers with varied experience in PET/CT.
METHODS: PET/CT images of 47 patients (59.8 ± 10.6 years, range 26-86 years) with head and neck cancer who had a baseline PET/CT at our institution (January 2007-May 2009) were retrieved and independently reviewed by four readers with varying experience reading PET/CT. Novice reader 1 was a preinternship medical student; novice reader 2 was a fourth-year radiology resident; expert reader 1 was a board-certified radiologist with a nuclear radiology fellowship and a junior faculty; and expert reader 2 was a dual radiology and nuclear medicine board-certified radiologist and a senior faculty. Intraclass correlation coefficients (ICCs) were estimated separately across novice and expert readers, between novice 1 and expert 1, and between novice 2 and expert 1 readers.
RESULTS: The ICCs (95% confidence interval) for primary tumor diameter, primary tumor SUVmax, and primary tumor SUVmax normalized to liver SUVmean within novices were 0.36 (0.09-0.59) (slight agreement), 0.60 (0.38-0.80) (fair agreement), and 0.91 (0.84-0.94) (almost perfect agreement), respectively. ICCs within experts were 0.84 (0.73-0.90) (almost perfect agreement), 0.91 (0.84-0.94) (almost perfect agreement), and 0.91 (0.84-0.95) (almost perfect agreement), respectively. The ICCs between novice 1 and experts are lower than those between novice 2 and experts for all parameters, and this disparity is greater for anatomic diameter than for fluorodeoxyglucose metabolic parameters.
CONCLUSION: Fluorodeoxyglucose metabolic parameters have higher interobserver agreement than anatomic diameter measurement and are more robust in the setting of varied reading experiences.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22227560     DOI: 10.1097/MNM.0b013e32834e5397

Source DB:  PubMed          Journal:  Nucl Med Commun        ISSN: 0143-3636            Impact factor:   1.690


  9 in total

1.  Interobserver and Intraobserver Variability among Measurements of FDG PET/CT Parameters in Pulmonary Tumors.

Authors:  Gülgün Büyükdereli; Mehtap Güler; Gülşah Şeydaoğlu
Journal:  Balkan Med J       Date:  2016-05-01       Impact factor: 2.021

2.  FDG-PET/CT imaging biomarkers in head and neck squamous cell carcinoma.

Authors:  Vasavi Paidpally; Alin Chirindel; Stella Lam; Nishant Agrawal; Harry Quon; Rathan M Subramaniam
Journal:  Imaging Med       Date:  2012-12

3.  Head and neck PET/CT: therapy response interpretation criteria (Hopkins Criteria)-interreader reliability, accuracy, and survival outcomes.

Authors:  Charles Marcus; Anthony Ciarallo; Abdel K Tahari; Esther Mena; Wayne Koch; Richard L Wahl; Ana P Kiess; Hyunseok Kang; Rathan M Subramaniam
Journal:  J Nucl Med       Date:  2014-06-19       Impact factor: 10.057

4.  Functional imaging of head and neck squamous cell carcinoma with diffusion-weighted MRI and FDG PET/CT: quantitative analysis of ADC and SUV.

Authors:  Arthur Varoquaux; Olivier Rager; Karl-Olof Lovblad; Karen Masterson; Pavel Dulguerov; Osman Ratib; Christoph D Becker; Minerva Becker
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-02-22       Impact factor: 9.236

5.  Interrater Agreement and Reliability of PERCIST and Visual Assessment When Using 18F-FDG-PET/CT for Response Monitoring of Metastatic Breast Cancer.

Authors:  Jonas S Sørensen; Mie H Vilstrup; Jorun Holm; Marianne Vogsen; Jakob L Bülow; Lasse Ljungstrøm; Poul-Erik Braad; Oke Gerke; Malene G Hildebrandt
Journal:  Diagnostics (Basel)       Date:  2020-11-24

Review 6.  Imaging intratumor heterogeneity: role in therapy response, resistance, and clinical outcome.

Authors:  James P B O'Connor; Chris J Rose; John C Waterton; Richard A D Carano; Geoff J M Parker; Alan Jackson
Journal:  Clin Cancer Res       Date:  2014-11-24       Impact factor: 12.531

7.  Differences among [18F]FDG PET-derived parameters in lung cancer produced by three software packages.

Authors:  Agnieszka Bos-Liedke; Paulina Cegla; Krzysztof Matuszewski; Ewelina Konstanty; Adam Piotrowski; Magdalena Gross; Julian Malicki; Maciej Kozak
Journal:  Sci Rep       Date:  2021-07-06       Impact factor: 4.379

8.  Advantages of Combined PET-CT in Mediastinal Staging in Patients with Non-small Cell Lung Carcinoma.

Authors:  Nermina Beslic; Amera Sadija; Renata Milardovic; Timur Ceric; Sejla Ceric; Adnan Beganovic; Spomenka Kristic; Semra Cavaljuga
Journal:  Acta Inform Med       Date:  2016-03-26

9.  Inter-observer agreement improves with PERCIST 1.0 as opposed to qualitative evaluation in non-small cell lung cancer patients evaluated with F-18-FDG PET/CT early in the course of chemo-radiotherapy.

Authors:  Joan Fledelius; Azza Khalil; Karin Hjorthaug; Jørgen Frøkiær
Journal:  EJNMMI Res       Date:  2016-09-22       Impact factor: 3.138

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.